Introduction
The role of tumor-derived molecules in enhancing tumor formation is increasingly recognized. Acting either on the tumor cell itself or on the host, these molecules may favorably alter the tumor cell microenvironment to enhance tumor implantation and progression. Well-known tumor-derived molecules with such activities include cytokines and chemokines. Another class of molecules that may alter the tumor host microenvironment are tumor-derived gangliosides. These sialic acid-containing glycosphingolipids are components of the outer leaflet of plasma membranes, with their hydrophobic ceramide portion anchored in the membrane and the hydrophilic oligosaccharide chain facing the extracellular environment. They are frequently present in high concentrations in the membranes of tumor cells and are actively shed into their microenvironment (Ladisch et al., 1983 (Ladisch et al., , 1987 Young et al., 1986; Portoukalian et al., 1993; Chang et al., 1997) , in the form of micelles, monomers, and membrane vesicles (Kong et al., 1998; Dolo et al., 2000) .
Gangliosides have a range of biological properties. They enhance the growth factor-mediated proliferation of fibroblasts and the proliferation and migration of human vascular endothelial cells (Lang et al., 2001) , and they exert potent immunosuppressive activity (Ladisch et al., 1983; Floutsis et al., 1989; Lu and Sharom, 1996) . By multiple mechanisms, gangliosides inhibit normal human lymphoproliferative responses to mitogens and antigens (Gonwa et al., 1984) , interleukin 2-dependent cell proliferation (Robb, 1986) , antigen presenting cell function (Ladisch et al., 1984; Heitger and Ladisch, 1996) , helper T cell proliferation (Chu and Sharom, 1995) , and NK cell activity (Bergelson et al., 1989) , and they enhance apoptosis of thymocytes (Zhou et al., 1998) . Because of their cell surface location, gangliosides are likely to be involved in various membrane-triggered cellular functions, including signal transduction, regulation of cell proliferation and differentiation, and cell death (De Maria et al., 1997; Iwabuchi et al., 1998; Kopitz et al., 1998) . Evidence implicating tumor gangliosides in modulating tumor formation in vivo includes (1) a correlation between tumor cell ganglioside content and tumor forming ability and (2) direct experiments showing that addition of tumor gangliosides to the tumor cell inoculum enhances tumor formation in vivo (Ladisch et al., 1987) .
MEB4 mouse melanoma is characterized by high expression of NeuNAc2-3Galβ1-4Glcβ1-1Cer (G M3 ) ganglioside; this high expression is associated with enhanced tumor formation in mice (Ichikawa et al., 1994) . Recently, we found that the pharmacologic inhibitor of glucosylceramide synthase, 1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol (PPPP) (Lee et al., 1999) , was effective in reducing ganglioside content and in inhibiting tumor formation and metastasis by MEB4 cells (Deng et al., 2000) . However, because the inhibition of ganglioside synthesis by PPPP can only be achieved with the constant presence of this inhibitor in the cell culture, and because cellular recovery from inhibition is relatively rapid (48-72 h after the removal of the inhibitor), we sought to develop a more permanent approach to the alteration of ganglioside metabolism in tumor cells.
Here we transfected MEB4 melanoma cells with an antisense sequence to the gene encoding glucosylceramide synthase. The highly specific inhibition of glucosylceramide synthase, a key 1 To whom correspondence should be addressed enzyme in the pathway of ganglioside synthesis, resulted in substantially reduced ganglioside content and markedly reduced tumorigenicity of these murine melanoma cells.
Results

Antisense vector construction and expression
A 1075 bp cDNA fragment of the gene encoding glucosylceramide synthase ( Figure 1A ) was obtained by reverse transcription polymerase chain reaction (RT-PCR) with a pair of specific primers. The forward primer, specific to nucleotides 82-102 of the cDNA, had the sequence AGTCCTGACGCGT-CATGGCTATCATCTACACCCGA. The reverse primer, to nucleotides 1108-1128, had the sequence AGTCCTGACGC-GTCTCTCCAGCTTATAGTTGGGTC. The resulting cDNA fragment was subcloned into the pCI-neo mammalian expression vector under the control of a CMV promoter. The orientation of the fragment in the vector was identified by restriction mapping with Hind III. The vector with the antisense-oriented insert yielded bands of 1176 bp, 1530 bp, and 3815 bp ( Figure 1B) , and the vector with the sense-oriented insert produced bands of 563 bp, 2143 bp, and 3815 bp ( Figure 1B ). By sequencing (DNA Sequencing Facility, University of Chicago Cancer Research Center) both the antisense and sense vectors were confirmed to contain the correct cDNA insert with the correct orientation.
We then generated a number of cell clones by transfection of MEB4 cells with either the antisense vector or the sense vector and selection with G418. The expression of antisense mRNA in antisense-transfected clones was confirmed by RT-PCR using a pair of specific primers. They were TACGACTCACTATA-GGCTAGC (nucleotides 1070-1090 of the sense sequence on the vector) and ATCAGGTGGACCAAACTACGA (nucleotides 1110-1130 of the sense sequence on the cDNA), which were designed to amplify only the antisense transcript expressed from the antisense vector. As shown in Figure 2 , a 349-bp band was amplified in an antisense vector transfected cell clone, designated MA173, indicating that the antisense vector successfully expressed itself. This antisense-transfected clone was then subjected to the further studies. 
Ceramide, glucosylceramide, and ganglioside concentrations in antisense-transfected cells
We used several approaches to assess the glycosphingolipids of the antisense-transfected MA173 cells. First, we measured the rate of conversion of UDP-glucose to glucosylceramide and other glycosphingolipids in these cells and control MEB4 cells. The cells were radiolabeled with 14 C-UDP-glucose for 18 h, harvested, total lipids extracted, and the neutral glycosphingolipids (NGSLs) separated by partition using di-isopropyl ether/ 1-butanol/0.1% aqueous NaCl. After recovery from the upper organic phase, the NGSLs were further analyzed by β-scintillation counting and high-performance thin-layer chromatography (HPTLC). The radioactivity of total NGSLs in MA173 cells was 53% of that of the control MEB4 cells (9.1 versus 17.1 × 10 3 dpm/10 6 cells/h) and, as detected by HPTLC autoradiography, included a marked specific reduction (90%) of incorporation of UDP-glucose into glucosylceramide, the direct product of glucosylceramide synthase.
In a second approach we used 3 H-serine to metabolically radiolabel cellular ceramide and glucosylceramide. Here we observed a 60% reduction in glucosylceramide content by HPTLC autoradiography ( Figure 3B ). Following autoradiography, the HPTLC bands were visualized with iodine vapor, scraped off the plate, and quantified by scintillation counting. In MA173 cells the radiolabeled glucosylceramide concentration was decreased by 65%, to 4.2 × 10 3 dpm or 0.96 nmol/10 7 cells from 12.2 × 10 3 dpm or 1.8 nmol/10 7 MEB4 cells. The level of ceramide was somewhat increased, to 1863 dpm or 2.15 nmol/10 7 cells from 860 dpm or 0.98 nmol/10 7 MEB4 cells ( Figure 3B ). These combined findings clearly demonstrate that antisense transfection was highly efficient in inhibiting glucosylceramide synthase activity.
The major ganglioside of MEB4 cells was previously determined to be G M3 (Deng et al., 2000) . Using the resorcinol assay and HPTLC densitometry, we quantified the ganglioside content of the sense-and antisense-expressing clones. The parent MEB4 cell line contained 44.2 nmol gangliosides/10 8 cells, and the ganglioside content of the antisense expressing clone, MA173, was reduced by 56% to 20.4 nmol/10 8 cells ( Figure 4 , Table I ). In contrast, the ganglioside content of the sense-transfected clone, MS2, was not reduced (Figure 4 , Table I ). G M3 ganglioside content was further analyzed by fluorescence-activated cell sorting (FACS) analysis using the murine anti-G M3 antibody DH2 and phycoerythrin-conjugated goat-anti-mouse antibody. Control MEB4 and antisense-transfected MA173 cells (2 × 10 5 ) were treated with a mild detergent, saplin, to create a temporarily permeable plasma membrane for antibody staining. FACS analysis confirmed a 58% reduction in the density of GM3 ganglioside in MA173 cells in comparison to the control MEB4 cells.
Effects of antisense transfection on morphology, cell growth, and apoptosis
Once this stable antisense transfectant containing reduced ganglioside content and the corresponding sense transfectant were identified, we evaluated the effect of this reduction on cell morphology and proliferation. The reduction of ganglioside content had no impact on cell morphology, demonstrated by the identical morphology of MEB4 and MA173 cells shown in Figure 5A and 5B. To assess proliferation, the cells were cultured for 1-4 days, pulsed with [ 3 H]thymidine for 4 h, and harvested, then cellular [ 3 H]thymidine uptake was quantified. MA173 and MEB4 cells had similar proliferation kinetics ( Figure 5C ). Furthermore, from daily cell counts performed in parallel with the measurement of thymidine incorporation, the doubling times of MEB4 and MA173 cells were determined to be 23.1 and 23.7 h, respectively. Finally, using flow cytometry to assess for apoptotic cells, we found that the degree of apoptosis in cultures of MA173 and MEB4 cells was nearly equal: 3.3% and 2.7%, respectively. 
Effect of antisense transfection on MEB4 cell tumorigenicity
The stably antisense-transfected cell line MA173 and sensetransfected cell line MS2 provided us with ideal tools for investigating the role of gangliosides in tumor formation, because ganglioside content is constantly reduced in MA173 cells without the use of an exogenous pharmacologic agent. We tested tumorigenicity by intradermal (ID) injection of control MEB4 cells, MS2 sense-transfected cells, and MA173 antisense-transfected cells in syngeneic C57B1/6 mice. The cells were cultured until subconfluent, harvested, and resuspended in 0.9% NaCl. Cells (1 × 10 4 or 1 × 10 5 ) cells were injected. As shown in Figure 
Discussion
This study demonstrates the effectiveness of antisense transfection in stably reducing the total cellular ganglioside content of MEB4 cells through inhibition of glycosphingolipid synthesis. The inhibition of glucosylceramide synthesis resulted in a significant reduction in tumorigenicity of MEB4 cells. In contrast, proliferation kinetics, cell morphology, and rate of apoptosis all were unaffected. Thus the alteration in glycosphingolipids in itself did not appear to have significant impact on intrinsic cell behavior in vitro, whereas it has a significant impact on tumor formation in vivo, underlining the potential importance of these molecules in modifying tumor cell-host interactions. In earlier studies, pharmacologic inhibition of ganglioside synthesis were used to block endogenous cellular ganglioside production. The first such molecule was D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, an inhibitor of glucosylceramide synthase (Inokuchi et al., 1990; Radin, 1994; . Recently we used the improved, more potent inhibitor PPPP (Lee et al., 1999) to inhibit ganglioside synthesis of MEB4 cells. Treatment of MEB4 cells with 0.5 µM PPPP for 4 days resulted in a significant reduction of ganglioside content of MEB4 cells (Deng et al., 2000) . However, a rapid reversal of the inhibition of ganglioside synthesis was seen when PPPP was removed from the culture medium, and ganglioside content recovered to the original level within 3 days. The requirement of continuing presence of an exogenous inhibitor for efficient inhibition is a disadvantage of this approach.
Two alternative approaches to modify ganglioside synthesis that have been explored by others are antisense oligodeoxynucleotide administration and antisense transfection. Treatment of the human promyelocytic leukemia cell line HL-60 with an antisense oligodeoxynucleotide to II 3 NeuNAcGgOse 3 Cer (G M2 ) synthase down-regulated the synthesis of G M2 and the more complex ganglioside II 3 NeuNAcGgOse 4 Cer (G M1 ) by 50%. Specificity of the effect was suggested by a concomitant increase in G M3 content without a change in total cellular ganglioside content. Antisense oligodeoxynucleotides to NeuNAc2-8NeuNAc2-3Galβ1-4Glcβ1-1Cer (G D3 ) synthase were also used to interfere with ganglioside synthesis (Zeng et al., 1995) and to study the function of G D3 in cell apoptosis (De Maria et al., 1997) . The drawback of antisense oligodeoxynucleotide administration is that oligodeoxynucleotides must be constantly present in the cell culture to achieve sustained inhibition of ganglioside synthesis. This is the same disadvantage as that of standard pharmacological inhibition. Antisense transfection, on the other hand, could provide a way to alter permanently the kinetics of glycosphingolipid synthesis. In the only published study of alteration of ganglioside metabolism using this technique, the G D3 level in rat F11 hybrid neuroblastoma cells was reduced by stable transfection of an antisense vector to G D3 synthase (Zeng et al., 1999) . This was associated with reduced cell migration in vitro and reduced metastatic potential in a nude mouse model (Zeng et al., 2000) . Though both of these antisense studies targeted the synthesis of a specific ganglioside (G M2 or G D3 ), the reduction of total cellular gangliosides by antisense transfection has not been reported.
Here we provide a first demonstration that the ganglioside level of cells can be permanently reduced by transfection of cells with an antisense vector targeting glucosylceramide synthase. The resulting cell line, MA173, expressed the antisense RNA and showed reduction in half of both glucosylceramide and G M3 ganglioside content. Also, synthesis of metabolically radiolabeled glucosylceramide (Ichikawa et al., 1994) in MA173 cells was greatly reduced, suggesting that glucosylceramide synthase activity was efficiently inhibited.
The reduction of tumor formation associated with the inhibition of glucosylceramide synthesis by antisense transfection was striking and shows that reduction of tumor cell glycosphingolipids is associated with significantly reduced tumor incidence. These results are consistent with our previous findings using the pharmacologic inhibitor PPPP (Deng et al., 2000) , in which reduction of tumor cell glycosphingolipids was also associated with significant reduction in tumor incidence. In the present study, the constitutive inhibition of ganglioside synthesis circumvented possible complications that could result from the recovery of ganglioside synthesis after the removal of an inhibitor.
The mechanism(s) underlying significant inhibition of tumor formation after inhibition of glucosylceramide synthesis remain to be elucidated. Several possible mechanisms must be considered. First, because inhibition of glucosylceramide synthase may cause accumulation of ceramide (the substrate for this enzyme), and because elevated ceramide levels have been associated with increased apoptosis, the possibility that increased apoptotic cell death could be the cause of decreased tumorigenicity was investigated. In the MA173 cell line, in which ceramide was somewhat elevated, there was neither a reduction in cell viability nor an increase in apoptosis compared with the control MEB4 cells. These findings exclude decreased intrinsic cell survival as a cause for decreased tumor formation. Second is a possible effect of decreased concentrations of the neutral glycosphingolipid products of glucosylceramide synthase, glucosylceramide, and lactosylceramide. However, to the extent studied, NGSLs (lacking sialic acid) have not been found to affect host cell responses that may influence tumor formation (such as the cellular immune response), which are affected by their sialic acid-containing products, gangliosides (Lengle and Krishnaraj, 1979; Ladisch et al., 1992) .
Existing knowledge of these biological properties of gangliosides may give some clues to the mechanism of decreased tumor formation. One is that the inhibition of shedding caused by blockade of synthesis stops the release of immunosuppressive gangliosides , which act to inhibit host immune responses to tumors through suppression of immune cell function at the tumor site (Ladisch et al., 1987; Li et al., 1995; McKallip et al., 1999) . Most recently we have obtained direct evidence that G M1b ganglioside shed by a murine lymphoma inhibits the specific immune response against this syngeneic tumor in vivo, including the primary anti-tumor immune response, the secondary response, and the generation of tumor-specific cytotoxic lymphocytes (McKallip et al., 1999) . Another property that may be operative is ganglioside enhancement of growth factor-mediated proliferation of normal fibroblasts and of human vascular endothelial cells (Lang et al., 2001) , important in tumor-associated angiogenesis. Although the cellular mechanisms remain to be fully elucidated, the significant reduction of tumor formation by antisense transfection of glucosylceramide synthase suggests that highly specific pharmacologic interference with glycosphingolipid metabolism warrants further study as a potential experimental therapeutic approach to cancer.
Materials and methods
Cell lines and culture conditions
MEB4 cells (Ichikawa et al., 1994) , a subline of B16 murine melanoma cells, were obtained from the RIKEN Cell Bank (Saitama, Japan). The cells were maintained in Dulbecco's modified Eagle's medium enriched in glucose, glutamine, and sodium pyruvate (Gibco), and supplemented with 10% heatinactivated fetal bovine serum. Cultures were maintained under 5% CO 2 in a humidified incubator at 37°C.
Vector construction and transfection
A glucosylceramide synthase cDNA fragment corresponding to the nucleotides 82-1128 of the published sequence of human glucosylceramide synthase (Ichikawa et al., 1996) was obtained by RT-PCR from total human RNA (human medulloblastoma DAOY cells) with two primers: AGTCCTGACGC-GTCATGGCTATCATCTACACCCGA (forward primer specific to nucleotides 82-102) and AGTCCTGACGCGTCTCTCCA-GCTTATAGTTGGGTC (reverse primer specific to nucleotide of 1108-1128). Both primers contain an extra 14-nucleotide segment, which has a restriction site for Mlu-1 endonuclease. The restriction site permits the cloning of the 1075-bp-long cDNA fragment into the polylinker region of the pCI-neo mammalian expression vector at the Mlu-1 site. The orientation of inserts was identified by restriction mapping with Hind III enzyme, for which there is one restriction site on the inserts and two sites on the vector. Antisense and sense vectors were identified by different digestion patterns, with three distinguishable bands.
MEB4 cells were transfected by electroporation using the gene pulser II (Bio-Rad) at 375 µF and 500 V. Stable transfectants were selected by incubating the cells in 1 mg/ml of the antibiotic G-418 for 10-14 days beginning 2 days after the electroporation. Individual surviving and proliferating colonies were then collected and cultured in fresh medium containing 500 µg/ml G418. The transfection efficiency was about 0.05%, which is the range of anticipated efficiency by electroporation (Potter, 1996) .
Antisense expression by RT-PCR
Expression of the antisense was studied by RT-PCR with a pair of primers: TACGACTCACTATAGGCTAGC (the same sequence as a part of the polylinker region of the vector between the transcription starting point and the insert) and ATCAGGT-GGACCAAACTACGA (the same sequence as the nucleotides from 819 to 839). Successful use of this pair of primers to amplify the cDNA fragment, which is 349 bp in length, showed that the cDNA fragment was inserted into the vector in antisense orientation.
Flow cytometry
To determine cellular G M3 expression, 2 × 10 5 MEB4 cells or the transfectants were detached using trypsin, which was neutralized by adding 10-fold serum-containing medium. The cells were incubated for 1 h at 37°C to repair any membrane damage due to the trypsinization, resuspended in cold Hank's buffered saline solution (HBSS)/0.5% bovine serum albumin (BSA)/0.1% NaN 3 , sequentially incubated with DH2, a murine anti-G M3 antibody (Dohi et al., 1988) and phycoerythrinconjugated goat monoclonal anti-mouse antibody on ice for 30 min, and washed three times with HBSS/0.5% BSA/0.1% NaN 3 . To quantify apoptosis, cells were assessed (Schutte et al., 1995; Vermes et al., 1995) for expression of annexin V and uptake of 7-aminoactinomycin D. Apoptotic cells were identified as annexin V-positive, 7-aminoactinomycin D-negative. Flow cytometry was performed using a FACStar Plus flow cytometer (Becton Dickinson). Fluorescence was measured as molecules of equivalent soluble fluorochrome.
Lipid analyses of antisense-transfected cells
To assess the effect of the antisense transfection on incorporation of UDP-glucose into glucosylceramide, cells were cultured to subconfluence and then labeled with 5 µCi/ml 14 C-UDP-glucose for 18 h, harvested, and lyophilized. Ten nmol unlabeled G M3 ganglioside was added to the cells as a cold carrier before extraction twice with 5 ml chloroform:methanol (1:1). The combined extracts were dried down under N 2 , lyophilized, and partitioned twice with 2 ml di-isopropyl ether/1-butanol (60:40, by vol) and 1 ml 0.1% aqueous NaCl (Ladisch and Gillard, 1985) . The upper organic phases, which contain most of the NGSLs, were combined and dried down under N 2 , lyophilized, and redissolved in chloroform:methanol (1:1) for aliquoting for β-scintillation counting and HPTLC analysis.
Cell lipids were also analyzed by metabolic radiolabeling of the cells with 1.0 µCi/ml [ 3 H] serine (21.7 Ci/mmol, NEN). After a 24-h incubation, the cells were washed three times with phosphate buffered saline (PBS) and the cell pellet processed for sphingolipid analysis. For ceramide determination (Rani et al., 1995) , the pellet was extracted twice with 4 ml chloroform:methanol (1:1), centrifuged at 1000 × g for 10 min, and the supernatants pooled. Chloroform (5 ml) and 0.9% NaCl (4 ml) were added to the supernatants, which were then vortexed and centrifuged at 1000 × g. The lower phase was retained, dried under a nitrogen stream, and resuspended in chloroform:methanol (1:1), and the radioactivity determined by scintillation counting. For glucosylceramide determination (Lavie et al., 1997) , the pellets were resuspended in 2 ml methanol with 2% acetic acid. Unlabeled glucosylceramide (5 µg) was added as a carrier to aid in recovery. The lipids were extracted with 2 ml chloroform and 2 ml water, by vortexing, sonication, and centrifugation at 1000 × g for 10 min. The lower organic phase was retained, dried under a nitrogen stream, and radioactivity quantified.
Equivalent amounts of radiolabeled lipid extracts and unlabeled ceramide or glucosylceramide standards were analyzed by HPTLC following resolution in either chloroform:acetic acid (9:1) for ceramide or chloroform:methanol:ammonium hydroxide (65:25:5) for glucosylceramide. The HPTLC plate was split to separate the unlabeled standards, which were visualized by charring (Fewster et al., 1969) . The portion of the plate containing the radioactive lipids was sprayed with En 3 hance™ (NEN) and analyzed by HPTLC autoradiography by exposure of the plate to XRP X-ray film (Eastman Kodak, Rochester, NY). Densitometric scanning analysis of the samples was performed using a Scan Maker 5 scanner (Microtek) and Scion Image Analysis (NIH Image 160) software. To test for ceramide, after development of the HPTLC lipids were visualized by iodine vapor and the ceramide area was scraped into 0.5 ml water. Counting fluid was added, and the radioactivity was quantified by scintillation counting (Liu et al., 2000) . Total cellular protein was quantified by a modification of the Lowry method (Markwell et al., 1981) .
Gangliosides were also isolated from the cell pellets. The gangliosides were recovered from the final lower aqueous phase of the di-isopropyl ether/1-butanol partition method as described but without the addition of cold carrier. This aqueous phase was lyophilized and redissolved in a small volume of distilled water. Salts and low-molecular-weight impurities were removed from the total ganglioside fraction by Sephadex G-50 gel filtration. Gangliosides, recovered in the void volume, were lyophilized and quantified as nanomoles of lipid-bound sialic acid by the colorimetric resorcinol assay (Ledeen and Yu, 1982) . For HPTLC analysis, they were spotted on 10 × 20 cm precoated Silica Gel-60 HPTLC plates, which were then developed in chloroform:methanol, 0.25% CaCl 2 2H 2 O (60:40:9, by vol). Gangliosides were visualized as purple bands with resorcinol-HCl reagent (Ledeen and Yu, 1982) , and quantified by densitometry.
Cell proliferation assay
To assess the effect of antisense transfection on the proliferation kinetics of MEB4 cells, the cells were cultured in 96-well plates. Triplicate cultures were harvested daily for up to 4 days. Before harvesting, cells were incubated for 4 h with [ 3 H]thymidine at 3.3 µCi/ml and then rinsed twice with ice-cold PBS. Cells were detached in 1% trypsin/ethylenediamine tetra-acetic acid. Incorporated [ 3 H]thymidine was quantified by β-scintillation counting.
Tumorigenicity assay
Tumor formation was detected as the development of palpable tumors following ID injection of tumor cells. Female syngeneic C57BL/6 mice, 6-8 weeks old, were used. MEB4, MS2, and MA173 cells were washed in PBS and resuspended, and viability was assessed by trypan blue dye exclusion. Twenty microliters of the resuspended cells (10 4 or 10 5 cells) were injected ID on the back of each mouse. The mice were examined for tumor formation twice weekly for 10 weeks.
Statistical analysis
To test significance of differences in the absolute proportion of tumors formed in each of the three groups at the final time point, a logistic regression was performed on data for each cell number administered (10 4 or 10 5 ). Logistic regression allowed estimation of odds ratios (ratio of the odds of tumor production between two groups). Because 10 5 control MEB4 cells/mouse caused a 100% tumor incidence at 8 weeks, we used an exact logistic procedure to examine these odds ratios and test significance, using LogExact software. To examine the proportion of tumors over time a generalized estimating equation approach was used; this allows for the testing of the difference in tumor growth between the three groups over the entire study period.
